360 High-Risk Vulnerability Immunization Tool V2.0 vs Microsoft Defender for Endpoint: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Microsoft Defender for Endpoint: Multiplatform endpoint security with detection and response capabilities. built by Microsoft. Core capabilities include Endpoint detection and response (EDR), Automatic attack disruption for ransomware, Exposure management..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Microsoft Defender for Endpoint differentiates with Endpoint detection and response (EDR), Automatic attack disruption for ransomware, Exposure management.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Microsoft Defender for Endpoint is developed by Microsoft. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and Microsoft Defender for Endpoint serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.